JANE STREET GROUP, LLC - LYELL IMMUNOPHARMA INC ownership

LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 93 filers reported holding LYELL IMMUNOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of LYELL IMMUNOPHARMA INC
ValueSharesWeighting
Q3 2023$21,682
-89.0%
14,750
-76.2%
0.00%
Q2 2023$197,392
-57.7%
62,073
-68.6%
0.00%
Q1 2023$466,239
+448.5%
197,559
+1411.7%
0.00%
Q2 2022$85,000
-37.5%
13,069
-51.4%
0.00%
Q1 2022$136,000
-80.2%
26,872
-69.8%
0.00%
Q4 2021$688,000
+133.2%
88,933
+345.6%
0.00%
Q3 2021$295,00019,9600.00%
Other shareholders
LYELL IMMUNOPHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 20,162,332$156,056,00045.49%
Foresite Capital Management IV, LLC 13,282,181$102,804,00021.15%
Apoletto Ltd 15,093,969$116,827,00014.55%
SB Management Ltd 3,500,000$27,090,0002.68%
HSG Holding Ltd 3,045,997$23,576,0002.11%
MIC Capital Management UK LLP 1,320,000$10,217,0001.95%
Alphabet Inc. 5,865,125$45,396,0001.10%
Board of Trustees of The Leland Stanford Junior University 1,647,882$12,754,0000.80%
Adero Partners, LLC 491,372$3,803,0000.62%
Ergoteles LLC 1,008,428$7,805,0000.30%
View complete list of LYELL IMMUNOPHARMA INC shareholders